Evert Kroon

9.7k total citations · 5 hit papers
29 papers, 7.1k citations indexed

About

Evert Kroon is a scholar working on Surgery, Molecular Biology and Genetics. According to data from OpenAlex, Evert Kroon has authored 29 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Surgery, 16 papers in Molecular Biology and 11 papers in Genetics. Recurrent topics in Evert Kroon's work include Pancreatic function and diabetes (16 papers), Diabetes Management and Research (9 papers) and Diabetes and associated disorders (8 papers). Evert Kroon is often cited by papers focused on Pancreatic function and diabetes (16 papers), Diabetes Management and Research (9 papers) and Diabetes and associated disorders (8 papers). Evert Kroon collaborates with scholars based in United States, Canada and Belgium. Evert Kroon's co-authors include Kevin A. D’Amour, Olivia Kelly, Emmanuel E. Baetge, Alan D. Agulnick, Susan Eliazer, Anne G. Bang, Melissa K. Carpenter, Nora G. Smart, Mark A. Moorman and Guy Sauvageau and has published in prestigious journals such as Journal of Biological Chemistry, Nature Medicine and The EMBO Journal.

In The Last Decade

Evert Kroon

28 papers receiving 6.9k citations

Hit Papers

Production of pancreatic hormone–expressing endocrine cel... 1998 2026 2007 2016 2006 2008 2005 1998 2021 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells
    2006 1.5k citations Kevin A. D’Amour, Anne G. Bang et al. Nature Biotechnology profile →
  2. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo
    2008 1.3k citations Evert Kroon, Laura A. Martinson et al. Nature Biotechnology profile →
  3. Efficient differentiation of human embryonic stem cells to definitive endoderm
    2005 1.3k citations Kevin A. D’Amour, Alan D. Agulnick et al. Nature Biotechnology profile →
  4. Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b
    1998 513 citations Evert Kroon The EMBO Journal profile →
  5. Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device
    2021 189 citations A. M. James Shapiro, David Thompson et al. Cell Reports Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Evert Kroon United States 23 4.8k 4.2k 1.9k 1.4k 806 29 7.1k
Alan D. Agulnick United States 16 3.7k 0.8× 3.4k 0.8× 1.5k 0.8× 999 0.7× 74 0.1× 20 5.3k
Paul Gadue United States 34 3.5k 0.7× 1.1k 0.3× 560 0.3× 122 0.1× 532 0.7× 89 4.9k
Holger Willenbring United States 34 2.9k 0.6× 2.6k 0.6× 410 0.2× 134 0.1× 175 0.2× 54 6.0k
William C. Bowen United States 33 2.1k 0.4× 2.5k 0.6× 241 0.1× 103 0.1× 162 0.2× 66 5.2k
Tomoyuki Yamaguchi Japan 24 1.9k 0.4× 976 0.2× 480 0.3× 56 0.0× 546 0.7× 85 3.3k
Susan Eliazer United States 14 3.5k 0.7× 3.2k 0.8× 1.3k 0.7× 904 0.7× 12 0.0× 14 4.8k
M. Cristina Nostro Canada 24 1.6k 0.3× 1.5k 0.4× 526 0.3× 405 0.3× 46 0.1× 44 2.4k
Elisa Vigna Italy 27 2.6k 0.5× 1.1k 0.3× 619 0.3× 92 0.1× 185 0.2× 54 4.6k
Nathan Bucay United States 19 3.7k 0.8× 694 0.2× 507 0.3× 181 0.1× 92 0.1× 30 5.0k
Holger A. Russ United States 26 1.7k 0.4× 2.3k 0.6× 1.3k 0.7× 979 0.7× 14 0.0× 56 3.3k

Countries citing papers authored by Evert Kroon

Since Specialization
Citations

This map shows the geographic impact of Evert Kroon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Evert Kroon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Evert Kroon more than expected).

Fields of papers citing papers by Evert Kroon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Evert Kroon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Evert Kroon. The network helps show where Evert Kroon may publish in the future.

Co-authorship network of co-authors of Evert Kroon

This figure shows the co-authorship network connecting the top 25 collaborators of Evert Kroon. A scholar is included among the top collaborators of Evert Kroon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Evert Kroon. Evert Kroon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keymeulen, Bart, Daniel Jacobs‐Tulleneers‐Thevissen, David Thompson, et al.. (2023). Encapsulated stem cell–derived β cells exert glucose control in patients with type 1 diabetes. Nature Biotechnology. 42(10). 1507–1514. 53 indexed citations
2.
Shapiro, A. M. James, David Thompson, Thomas Donner, et al.. (2021). Insulin expression and C-peptide in type 1 diabetes subjects implanted with stem cell-derived pancreatic endoderm cells in an encapsulation device. Cell Reports Medicine. 2(12). 100466–100466. 189 indexed citations breakdown →
3.
Stangé, Geert, Zhidong Ling, Robert Hilbrands, et al.. (2020). Formation of amyloid in encapsulated human pancreatic and human stem cell-generated beta cell implants. American Journal of Transplantation. 21(6). 2090–2099. 3 indexed citations
4.
Stangé, Geert, et al.. (2018). Functional Beta Cell Mass from Device-Encapsulated hESC-Derived Pancreatic Endoderm Achieving Metabolic Control. Stem Cell Reports. 10(3). 739–750. 57 indexed citations
5.
Zaldumbide, Arnaud, Gaby Duinkerken, Mark Peakman, et al.. (2016). Immunogenicity of human embryonic stem cell-derived beta cells. Diabetologia. 60(1). 126–133. 40 indexed citations
6.
Szepessy, Edit, Geert Stangé, Daniel Jacobs‐Tulleneers‐Thevissen, et al.. (2014). Composition and function of macroencapsulated human embryonic stem cell-derived implants: comparison with clinical human islet cell grafts. American Journal of Physiology-Endocrinology and Metabolism. 307(9). E838–E846. 76 indexed citations
7.
Szot, Gregory L., Mahesh Yadav, Jiena Lang, et al.. (2014). Tolerance Induction and Reversal of Diabetes in Mice Transplanted with Human Embryonic Stem Cell-Derived Pancreatic Endoderm. Cell stem cell. 16(2). 148–157. 80 indexed citations
8.
Xie, Ruiyu, Logan J. Everett, Hee‐Woong Lim, et al.. (2013). Dynamic Chromatin Remodeling Mediated by Polycomb Proteins Orchestrates Pancreatic Differentiation of Human Embryonic Stem Cells. Cell stem cell. 12(2). 224–237. 181 indexed citations
9.
Sauvageau, Guy, Unnur Thorsteinsdottir, Aline Mamo, et al.. (2013). marrow cells induces stem cell expansion associatedHoxa9 gene in bone - Overexpression of the myeloid leukemia.
10.
Wolfs, Tim G. A. M., Suhas G. Kallapur, Christine L. Knox, et al.. (2012). Antenatal ureaplasma infection impairs development of the fetal ovine gut in an IL-1-dependent manner. Mucosal Immunology. 6(3). 547–556. 40 indexed citations
11.
Kelly, Olivia, Laura A. Martinson, Kuniko Kadoya, et al.. (2011). Cell-surface markers for the isolation of pancreatic cell types derived from human embryonic stem cells. Nature Biotechnology. 29(8). 750–756. 257 indexed citations
12.
Kroon, Evert, Laura A. Martinson, Kuniko Kadoya, et al.. (2008). Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nature Biotechnology. 26(4). 443–452. 1346 indexed citations breakdown →
13.
D’Amour, Kevin A., Anne G. Bang, Susan Eliazer, et al.. (2006). Production of pancreatic hormone–expressing endocrine cells from human embryonic stem cells. Nature Biotechnology. 24(11). 1392–1401. 1469 indexed citations breakdown →
14.
D’Amour, Kevin A., Alan D. Agulnick, Susan Eliazer, et al.. (2005). Efficient differentiation of human embryonic stem cells to definitive endoderm. Nature Biotechnology. 23(12). 1534–1541. 1327 indexed citations breakdown →
15.
Krošl, Jana, Pamela Austin, Nathalie Beslu, et al.. (2003). In vitro expansion of hematopoietic stem cells by recombinant TAT-HOXB4 protein. Nature Medicine. 9(11). 1428–1432. 229 indexed citations
16.
Kroon, Evert. (2001). NUP98-HOXA9 expression in hemopoietic stem cells induces chronic and acute myeloid leukemias in mice. The EMBO Journal. 20(3). 350–361. 175 indexed citations
17.
Þorsteinsdóttir, Unnur, et al.. (1999). The Oncoprotein E2A-Pbx1a Collaborates with Hoxa9 To Acutely Transform Primary Bone Marrow Cells. Molecular and Cellular Biology. 19(9). 6355–6366. 62 indexed citations
18.
Kroon, Evert. (1998). Hoxa9 transforms primary bone marrow cells through specific collaboration with Meis1a but not Pbx1b. The EMBO Journal. 17(13). 3714–3725. 513 indexed citations breakdown →
19.
Kroon, Evert, Raymond J. MacDonald, & Robert E. Hammer. (1997). The transcriptional regulatory strategy of the rat tissue kallikrein gene family. PubMed. 1(5). 309–319. 8 indexed citations
20.
MacDonald, Raymond J., E. Michelle Southard‐Smith, & Evert Kroon. (1996). Disparate Tissue-specific Expression of Members of the Tissue Kallikrein Multigene Family of the Rat. Journal of Biological Chemistry. 271(23). 13684–13690. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Alan D. Agulnick Breakdown of academic impact, for papers by Paul Gadue Breakdown of academic impact, for papers by Holger Willenbring Breakdown of academic impact, for papers by William C. Bowen Breakdown of academic impact, for papers by Tomoyuki Yamaguchi Breakdown of academic impact, for papers by Susan Eliazer Breakdown of academic impact, for papers by M. Cristina Nostro Breakdown of academic impact, for papers by Elisa Vigna Breakdown of academic impact, for papers by Nathan Bucay Breakdown of academic impact, for papers by Holger A. Russ
Rankless by CCL
2026